Streetbeat News

THCX

Investment Managers Series Trust II

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Cannabis ETFs are experiencing dynamic changes due to significant regulatory shifts, notably the Department of Health and Human Services' recommendation to reclassify cannabis, and growing Congressional support. The introduction of swap options for U.S. Multi-State Operators (MSOs) has allowed ETFs like MSOS to navigate federal restrictions, leading to a notable performance disparity among cannabis ETFs. MSOX has seen an 88.4% increase YTD, while THCX and POTX are set to close due to challenges from lacking U.S. MSO swap exposure.

Portfolio Pulse from Patricio Liddle

February 09, 2024 | 5:13 pm

Benzinga PotProfits, led by Michael Berger, is offering investment opportunities in the cannabis sector, promising over 10% returns within a 90-day frame. The platform has a 4.5-star rating on Marketfy and offers a 30-day money-back guarantee. The article also mentions several ETFs in the cannabis space, including AdvisorShares Pure US Cannabis ETF, ETFMG US Alternative Harvest ETF, Amplify Seymour Cannabis ETF, AdvisorShares Pure Cannabis ETF, ETFMG Alternative Harvest, AXS Cannabis ETF, and Global X Cannabis ETF.

Portfolio Pulse from Javier Hasse

October 12, 2023 | 5:44 pm

IGC Pharma, Inc. (IGC) has expanded its Phase 2 clinical trial for IGC-AD1, a THC-based investigational drug for Alzheimer's disease, to the University of Puerto Rico network. The expansion aims to increase population diversity and representation of underrepresented groups. The trial will enroll 146 patients, half of whom will receive IGC-AD1 and the other half a placebo. The goal is to evaluate the drug's efficacy in reducing agitation, a symptom affecting 76% of Alzheimer's patients.

Portfolio Pulse from Nicolás Jose Rodriguez

August 04, 2023 | 12:21 pm

Denver has licensed its first cannabis consumption bus, while Maryland's recreational cannabis sales exceeded expectations with $85 million in the first month. An unlicensed cannabis dispensary in New York was shut down for selling to minors. The U.S. Senate approved a bill preventing denial of security clearances due to past marijuana use. The Office of National Drug Control Policy is working on a cohesive cannabis policy.

Portfolio Pulse from Nicolás Jose Rodriguez

August 04, 2023 | 10:39 am

Detroit is set to accept applications for the second round of limited marijuana business licenses, with half reserved for 'equity applicants'. The round offers 30 marijuana retailer licenses, 10 microbusiness licenses, and 10 consumption lounge licenses. The city is working to reduce zoning restrictions and guide applicants. Successful candidates will be notified six to eight weeks after the August 31 deadline. The article also mentions several cannabis-related ETFs.

Portfolio Pulse from Nicolás Jose Rodriguez

August 04, 2023 | 10:37 am

The potential rescheduling of cannabis and removal of Tax Rule 280E could boost profits for U.S. businesses, but Zuanic and Associates' report warns of complexities and overlooked consequences. Rescheduling medical marijuana (MMJ) could lead to stricter FDA regulations, limit prescription accessibility, and invite pharmaceutical companies into the industry. For Multi-State Operators (MSOs), rescheduling could alleviate the 280E burden but also introduce regulatory challenges. In 2022, 16 MSOs paid $761 million in corporate income tax, while the entire industry paid $1.2-1.5 billion.

Portfolio Pulse from Nicolás Jose Rodriguez

August 04, 2023 | 9:53 am

Analysts from Zuanic & Associates (Z&A) have discussed the potential impact of cannabis rescheduling on Multi-State Operators (MSOs) and cannabis stocks. They suggest that rescheduling may not be beneficial for MSOs and that the industry should consider the consequences of medical marijuana rescheduling. They also recommend lobbying for the removal of 280E without rescheduling. The report mentions several cannabis ETFs, including Cambria Cannabis ETF (TOKE), Amplify Seymour Cannabis ETF (CNBS), AdvisorShares Pure Cannabis ETF (YOLO), ETFMG Alternative Harvest (MJ), AXS Cannabis ETF (THCX), and Global X Cannabis ETF (POTX).

Portfolio Pulse from Nicolás Jose Rodriguez

July 31, 2023 | 10:14 pm

Missouri has implemented new regulations for the cannabis industry, granting officials the authority to impose fines, suspend operations, or revoke licenses for rule violations at public events. The state's Department of Health and Senior Services can now directly issue subpoenas to investigate licensed marijuana businesses and third-party entities. The news coincides with a rise in the share prices of several cannabis ETFs.

Portfolio Pulse from Joana Scopel

July 31, 2023 | 10:04 pm

Florida Governor Ron DeSantis has appointed six new members to the state's Drug Policy Advisory Council, including sheriffs and a pastor, to weigh in on Florida's cannabis reform. The council will provide recommendations to the governor's office. The panel includes sheriffs with contrasting stances on marijuana rights. As Florida activists aim to legalize cannabis through a ballot initiative, the panel members' past actions and statements related to drugs may influence the state's response.

Portfolio Pulse from Nicolás Jose Rodriguez

July 29, 2023 | 3:46 pm

Tantalus Labs Ltd. has received permission from a British Columbia Supreme Court to sell over 1,200 kilograms of marijuana to alleviate its financial troubles. In other news, Uruguay celebrates six years of legal marijuana sales, and Slovenia is being touted as a potential hub for premium cannabis production due to its clean environment. Several cannabis ETFs including Cambria Cannabis ETF (BATS:TOKE), Amplify Seymour Cannabis ETF (NYSE:CNBS), AdvisorShares Pure Cannabis ETF (NYSE:YOLO), ETFMG Alternative Harvest (NYSE:MJ), AXS Cannabis ETF (NYSE:THCX), and Global X Cannabis ETF (NASDAQ:POTX) have shown varied price actions.

Portfolio Pulse from Jelena Martinovic

July 28, 2023 | 9:38 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.